HomeHealth & LifestyleIs Ozempic Linked to Blindness? Experts Explain

Is Ozempic Linked to Blindness? Experts Explain

Date:

Related stories

  Ottawa Vows to Improve Vaccine Injury Support Program

Health Minister Marjorie Michel pledges to improve Canada’s...

  Report Reveals Ongoing Canadian Arms Shipments to Israel

Despite government denials, new data shows military goods from...

  Surrey Mayor Urges Ottawa to List Extortion Gangs as Terrorists

Mayor of Surrey calls on federal government to label...

 ‘Elbows Up’ Canada Day Merch Loses Steam, Vendors Report

Retailers see slowing sales of once-popular ‘elbows up’ merchandise,...

 Abortion Travel Persists Amid Shifting State Policies

Tens of thousands crossed state lines for abortion care...
spot_imgspot_img

Ozempic and vision loss have become a hot topic, sparking lawsuits and fear. While some studies suggest a connection, medical experts urge caution before jumping to conclusions.

Understanding the Rare Condition NAION

The concern centers on non-arteritic anterior ischemic optic neuropathy (NAION). This rare condition causes sudden vision loss when blood flow to the optic nerve drops. Doctors note it often affects people with diabetes, high blood pressure, or sleep apnea.

What Research Really Shows

Several studies have investigated whether semaglutide—the active ingredient in Ozempic and Wegovy—increases the risk of NAION.

  • A 2024 JAMA Ophthalmology study found that 11% of diabetic patients on semaglutide developed NAION, compared with 3% on other medications.

  • A 2025 analysis of over 37 million patients concluded that while a link exists, the risk is lower than first thought.

  • A third study, published in August 2025, showed only a tiny increase in cases—0.04% compared with 0.02% in non-users.

Why the Data Looks Complicated

Experts caution against reading too much into the numbers. Dr. Howard Krauss, a neuro-ophthalmologist, points out that specialty clinics like Mass Eye and Ear often treat extreme cases, which can skew results. He adds that people prescribed semaglutide may already face higher health risks that make NAION more likely, regardless of the drug.

Doctors Urge Context, Not Panic

Dr. Mir Ali calls NAION a “rare and unusual side effect,” stressing that the vast majority of Ozempic users never develop the condition. Dr. Joseph Rizzo adds, “The study does not prove cause and effect,” emphasizing that the research shows only a possible link—not certainty.

What About Non-Diabetic Patients?

So far, studies focus mainly on patients with diabetes or obesity. That means experts cannot yet say whether non-diabetic users face the same risk. Even so, doctors agree that more research is needed before making any definitive claims.

Key Takeaways for Patients

Right now, the evidence shows only an association, not proof that Ozempic causes vision loss. Doctors recommend:

  • Don’t panic if you take Ozempic or Wegovy.

  • Keep up with regular eye exams, especially if you have diabetes or related conditions.

  • Talk with your doctor about concerns, but remember that NAION remains very rare.

For now, the link between Ozempic and vision loss is far from settled. Experts say more research will determine whether the risk is real or overstated.

Stay tuned to Maple Wire for the next update on health, science, and breaking news.

Latest stories

spot_img

LEAVE A REPLY

Please enter your comment!
Please enter your name here